Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Exp Mol Pathol. 2009 Oct 2;88(1):210. doi: 10.1016/j.yexmp.2009.09.013

Figure 3. Soluble PECAM chimera does not affect circulating leukocyte counts.

Figure 3

Peripheral leukocyte counts are shown for each treatment group at two timepoints (day 9 and day 17). Values are shown as the number of white blood cells per ml of blood. Data are shown as the average +/− SEM for each treatment group. There are no significant differences between the means across all treatments groups at both timepoints (p<0.01)